Table 2 Levels of the different tested parameters in patients with and without the event.
| Event* | All patients | Mortality | Hospital admission | No events |
|---|---|---|---|---|
| n = 107 | n = 21 | n = 26 | n = 70 | |
| Variable | ||||
| EPC–CFU | 81.08 (67.5) | 98.48 (81.84) | 71.15 (58.55) | 77.29 (62.46) |
| NT‐pro‐BNP, pg/ml | 1942 (2626) | 3622 (7333) | 3784 (6587) | 1732 (2994) |
| hsCRP, μg/ml | 10.66 (26.59) | 14.95 (24.89) | 13.65 (19.52) | 8.68 (27.99) |
| VEGF, pg/ml | 69.53 (71.18) | 66.35 (41.65) | 77 (17.8) | 67.7 (50) |
EPC–CFU, endothelial progenitor cells–colony‐forming units; hsCRP, high‐sensitivity C‐reactive protein; NT‐pro‐BNP, N‐terminal pro‐B‐type natriuretic peptide; VEGF, vascular endothelial growth factor.
*10 patients had CHF‐related hospital admission prior to mortality event.
Values are given as mean (SD).